Literature DB >> 19152067

An extension of the real option approach to the evaluation of health care technologies: the case of positron emission tomography.

Paolo Pertile1.   

Abstract

This paper aims to incorporate option values into the economic evaluation of positron emission tomography (PET). The installation of this equipment requires a substantial capital outlay, while uncertainty, especially regarding the possibility of new applications, is relevant, because the evidence available is still insufficient. Treating the number of examinations to provide as a stochastic variable, the cost-effectiveness analysis is extended to include the value of flexibility both with respect to the timing of investment and to the size of the project. The threshold values of the stochastic variable that ensure the cost-effectiveness of a PET scan according to this approach are obtained as a function of the value of the incremental effectiveness.

Entities:  

Mesh:

Year:  2009        PMID: 19152067     DOI: 10.1007/s10754-008-9053-z

Source DB:  PubMed          Journal:  Int J Health Care Finance Econ        ISSN: 1389-6563


  11 in total

1.  Incorporating option values into the economic evaluation of health care technologies.

Authors:  S Palmer; P C Smith
Journal:  J Health Econ       Date:  2000-09       Impact factor: 3.883

Review 2.  A tabulated summary of the FDG PET literature.

Authors:  S S Gambhir; J Czernin; J Schwimmer; D H Silverman; R E Coleman; M E Phelps
Journal:  J Nucl Med       Date:  2001-05       Impact factor: 10.057

Review 3.  Positron emission tomography: establishing priorities for health technology assessment.

Authors:  G Robert; R Milne
Journal:  Health Technol Assess       Date:  1999       Impact factor: 4.014

4.  Overview of economic evaluation of positron-emission tomography.

Authors:  A Müller; D Stratmann-Schöne; T Klose; R Leidl
Journal:  Eur J Health Econ       Date:  2002

5.  Expected value of information and decision making in HTA.

Authors:  Simon Eckermann; Andrew R Willan
Journal:  Health Econ       Date:  2007-02       Impact factor: 3.046

6.  Globally optimal trial design for local decision making.

Authors:  Simon Eckermann; Andrew R Willan
Journal:  Health Econ       Date:  2009-02       Impact factor: 3.046

7.  Early initiation of highly active antiretroviral therapies for AIDS: dynamic choice with endogenous and exogenous learning.

Authors:  Pierre Lasserre; Jean-Paul Moatti; Antoine Soubeyran
Journal:  J Health Econ       Date:  2005-12-15       Impact factor: 3.883

8.  A real options approach to watchful waiting: theory and an illustration.

Authors:  Tarn Driffield; Peter C Smith
Journal:  Med Decis Making       Date:  2007 Mar-Apr       Impact factor: 2.583

9.  Primary staging of lymphomas: cost-effectiveness of FDG-PET versus computed tomography.

Authors:  T Klose; R Leidl; I Buchmann; H J Brambs; S N Reske
Journal:  Eur J Nucl Med       Date:  2000-10

10.  Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany.

Authors:  M Dietlein; K Weber; A Gandjour; D Moka; P Theissen; K W Lauterbach; H Schicha
Journal:  Eur J Nucl Med       Date:  2000-10
View more
  2 in total

1.  When to wait for more evidence? Real options analysis in proton therapy.

Authors:  Janneke P C Grutters; Keith R Abrams; Dirk de Ruysscher; Madelon Pijls-Johannesma; Hans J M Peters; Eric Beutner; Philippe Lambin; Manuela A Joore
Journal:  Oncologist       Date:  2011-12-06

Review 2.  A systematic review of PET and PET/CT in oncology: a way to personalize cancer treatment in a cost-effective manner?

Authors:  Astrid Langer
Journal:  BMC Health Serv Res       Date:  2010-10-08       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.